Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
JC Gutiérrez-Ramos, President and CEO, Synlogic
David Knezevic, CTO, Akselos
Rei Goffer, Cofounder & Chief Strategy Officer, ClimaCell
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
Austin Che Founder, Ginkgo Bioworks